Influence of incomplete neoadjuvant chemotherapy on esophageal carcinoma

ConclusionsWe suggest that perioperative outcomes and long-term prognosis of patients with locally advanced ESCC were not significantly influenced, even if the patients did not receive a complete cycle of NAC. When certain adverse events occur after the first cycle of NAC, we believe that it is nevertheless possible to discontinue chemotherapy.

http://link.springer.com/10.1007/s10147-018-1291-6

Source: International Journal of Clinical Oncology - May 11, 2018 Category: Cancer & Oncology Source Type: research